July 2024

By Lauren Berg (July 30, 2024, 10:05 PM EDT) — A New York federal judge Tuesday kept in place a jury’s verdict holding that lighting fixture company Lutron Electronics Co. willfully infringed rival GeigTech East Bay’s window shade patent, but said $34.6 million for damages is excessive and, instead, offered GeigTech $3.8 million or a […]

Part 2: WHAT Last month, we reviewed where the U.S. Olympic & Paralympic Committee (USOPC) derives its trademark rights—if you missed last month’s article, catch up here: June 2024 Article. This month, we are exploring what trademarks the USOPC owns, based on the statutes and case law we discussed last month. The USOPC and its

The head of the U.S. Patent and Trademark Office has ordered patent board judges to revisit a ruling on “an obvious typographical error” in a patent used by a Chinese company to try to eject a different patent involved in litigation surrounding programming used in real-time “camera-like” mapping. Source link

NFL quarterbacks are known for going head to head on the gridiron, but two of the NFL’s top QB’s are now squaring off in the trademark arena. Earlier this month, Lamar Jackson filed two oppositions against FL101, a company associated with Troy Aikman, for its applications to register the mark EIGHT in connection with various

The United States Patent and Trademark Office (USPTO) is holding a roundtable discussion, on August 5, 2024, about the intersection of AI technology and legal protections for individuals’ reputations and name, image, voice, likeness (NIL), and other indicators of identity. These rights of publicity are currently protected by a patchwork of inconsistent laws and common law

Zyxel Comms. Corp. v. UNM Rainforest Innovations, Appeal Nos. 2022-2220, -2250 (Fed. Cir. July 22, 2024) Our Case of the Week provided new guidance on amendment proceedings under the Patent Trial and Appeal Board’s 2019 Motion to Amend Pilot Program in AIA post-grant proceedings. The program allows for preliminary Board feedback and revisions to a

In Short The Situation: Senate Bill 150 (“S.B. 150”)—the Affordable Prescriptions for Patients Act of 2023—unanimously passed the Senate and would amend 35 U.S.C. § 272(e) to limit, under certain circumstances, the number of patents that a sponsor of an originator biological product, or RPS, may assert in an infringement action against a biosimilar applicant.

By Ivan Moreno (July 30, 2024, 7:05 PM EDT) — A startup that makes software to create voice-over narrations slammed a complaint in New York federal court from two voice actors who allege the company has used their voices without permission, saying they have not plausibly claimed that the voices they have heard on YouTube

The Unified Patent Court (UPC) is revolutionizing the way patents are enforced in Europe, and McDermott’s intellectual property team is here to help you navigate this dynamic landscape. Our Legal Lens on the Unified Patent Court newsletter is designed to keep patent holders and legal departments well-informed. And with an on-the-ground team in Germany, France,